Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...

British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...

Our bodies contain many different cell types, which are defined by the genes they express and the functions they carry out. Stem cells can differentiate into any type of cell, and in cellular ...

Scientists just extended the life of mice 7 percent thanks to gene reprogramming, according to a new paper released by the San Diego biotech company Rejuvenate Bio. The concept of gene reprogramming ...

A stride that marked the turn of the century—realizing the possibility of reprogramming embryonic and adult fibroblasts into pluripotent stem cells by the co-expression of only four gene ...

In a recent study posted to the bioRxiv* preprint server, researchers performed age-reversing experiments, in vivo and in vitro, in progeroid mice using gene therapy. Study: Gene Therapy Mediated ...

The result is a widely anticipated landmark for rejuvenation technology. A small biotech company claims it has used a technology called reprogramming to rejuvenate old mice and extend their lives, a ...

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on its wholly owned subsidiary Adimune, Inc.